SURGERY PARTNERS INC
SGRYNASDAQTrading Snapshot
- Day Range
- $1,005.96 β $1,028.13
- 52-Week Range
- $11.41 β $23.44
- Volume
- $5.66B
- Avg Volume
- $5.83B
- Shares Outstanding
- 130.8M
- Next Earnings
- Oct 31, 2026
Fundamentals Snapshot
- Annual Revenue
- $3.31B
- Last Q Revenue
- $849M
- P/E Ratio
- -21.3
- P/S Ratio
- 0.6x
- EPS (TTM)
- $-0.69
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.8%
Why Investors Own SGRY
- βHigh-growth profile β revenue up +0.4% YoY with expanding US Equity exposure.
- βHealthy economics β 48% gross margin and 17% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SURGERY PARTNERS INC
SGRYAbout SURGERY PARTNERS INC
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilitiesβspecifically, 108 ambulatory surgical centers and 18 surgical hospitalsβsituated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
SURGERY PARTNERS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift SGRY price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
SURGERY PARTNERS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.